 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2021, vol. 27, issue1
Subject Area: Medicine
-
DOI: 10.5272/jimab.2021271.3630
Published online: 25 March 2021
Original article
J of IMAB. 2021 Jan-Mar;27(1):3630-3633
DISTRIBUTION OF MYCOPLASMA SPP. AND UREAPLASMA SPP. AMONG PREGNANT WOMEN
Anton G. Petrov1
, Vladislav M. Nankov2, Rositsa V. Petrova3, Irena I. Gencheva4, Milena D. Karcheva5,
1) Department of Obstetrics and Gynecology, Faculty of Medicine, Medical University-Pleven, Pleven, Bulgaria.
2) University Research Laboratory, Medical University - Pleven, Bulgaria.
3) Department of Hygiene, Medical Ecology, Professional Diseases and Disaster Medicine,Faculty of Public Health, Medical University-Pleven, Bulgaria.
4) Department of Clinical Immunology, Allergology and Clinical Laboratory, Faculty of Health Care, Medical University - Pleven, Bulgaria.
5) Department of Epidemiology, Parasitology and Tropical Medicine, Faculty of Public Health, Medical University - Pleven, Bulgaria.
ABSTRACT:
The purpose of the present study is to determine the prevalence of genital mycoplasmas (M. genitalium, M. hominis, U. parvum, U. urealyticum) in pregnant women by molecular biological methods.
Material/Methods: A prospective epidemiological study of 107 pregnant women hospitalized in the Clinic of Obstetrics and Gynecology, University Hospital-Pleven, Bulgaria, was conducted. Vaginal secretion samples were taken from all 107 pregnant women. A Polymerase chain reaction (PCR) assay was used to detect the genomic DNA of the bacteria in pregnant women.
Results: The highest is the relative share of women in the age group from 20 to 35 years - 66 (64.68%), followed by women under 20 years - 27 (25.23%) and women over 35 years - 14 (13.08%). Detection of bacterial DNA was found in 85 (79.44%) of the cases, with present Ureaplasma spp. Colonization in 42 women (39.25%). Although no statistical dependence was found on open bacteria and age groups (p-value = 0.4688), it is noteworthy that the prevalence of Mycoplasma spp. and Ureaplasma spp. as a whole in the age group from 20 to 35 years, which has the highest birth rate, is more than twice higher than the group of up to 20 years and more than five times higher compared to the group over 35 years.
Conclusions: Studies on the incidence of Mycoplasma spp. and Ureaplasma spp. in pregnant women is important for controlling the pregnancy, predicting the risk of developing maternal-fetal infection and discussing the options for timely treatment.
Keywords: Mycoplasma spp., Ureaplasma spp., pregnant women, Polymerase chain reaction,
- Download FULL TEXT /PDF 694 KB/
Please cite this article as: Petrov AG, Nankov VM, Petrova RV, Gencheva II, Karcheva MD. Distribution of Mycoplasma spp. and Ureaplasma spp. among pregnant women. J of IMAB. 2021 Jan-Mar;27(1):3630-3633. DOI: 10.5272/jimab.2021271.3630
Correspondence to: Anton Georgiev, MD, Department of Obstetrics and Gynecology, Faculty of Medicine, Medical University-Pleven; 1, St. Kliment Ohridski Str., Pleven, Bulgaria; E-mail: antongeorgiev@abv.bg
REFERENCES:
1. Leli C, Mencacci A, Latino MA, Clerici P, Rassu M, Perito S, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: An Italian observational multicentre study. J Microbiol Immunol Infect. 2018 Apr;51(2):220-225. [PubMed] [Crossref]
2. Safari M, Bakhshi A, Erami M, Kheirkhah B, Pourbakhsh A, Pourbabei H. Sequences of Mycoplasma hominis in patients with urinary tract infection in a Hospital in Kashan, Iran. Res J Microbiol. 2015;10(6):260-269. [Crossref]
3. Bayraktar MR, Ozerol IH, Gucluer N, Celik O. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis. 2010 Feb;14(2):e90-5. [PubMed] [Crossref]
4. Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Vanden Bosch T, Riphagen I, etal. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009 Sep;116(10):1315-24. [PubMed] [Crossref]
5. Moridi K, Hemmaty M, Azimian A, Fallah MH, Khaneghahi Abyaneh H, Ghazvini K. Epidemiology of genital infections caused by Mycoplasma hominis, M. Genitalium and Ureaplasma urealyticum in Iran; a systematic review and meta-analysis study (2000-2019). BMC Public Health. 2020 Jun 29;20(1):1020. [PubMed] [Crossref]
6. Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis. 1996 Oct;23(4):671-82; quiz 683-4. [PubMed] [Crossref]
6. Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. CurrOpin Infect Dis. 2013 Jun; 26(3):231-40. [PubMed] [Crossref]
7. Yamazaki T, Matsumoto M, Matsuo J, Abe K, Minami K, Yamaguchi H. Frequency of Chlamydia trachomatis in Ureaplasma-positive healthy women attending their first prenatal visit in a community hospital in Sapporo, Japan. BMC Infect Dis. 2012 Apr 2;12:82. [PubMed] [Crossref]
8. Tharpe N. Postpregnancy genital tract and wound infections. J Midwifery Women's Health. 2008 May-Jun;53(3):236-46. [PubMed] [Crossref].
Received: 19 June 2020
Published online: 25 March 2021